8
Oct
2024

Phyton Biotech LLC

Exhibitor at CPHI Milan 2024 stand 18G17, Pharma Machinery and Equipment
About Us

CDMO specializing in Upstream/Downstream Process Development and Scale-up
Pilot Fermentation Facility - 16L to 7500L tanks; Small Molecule Purification Capabilities; Semi-Synthesis - complex chemistry
Commercial Production and Global Distribution
Commercial Fermentation Facility 1 x 45,000L and 2 x 75,000L production tanks; metric tonne output capability; GMP - analytical and regulatory support; located in Germany and Canada

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CA
  • 2015
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer
Biopharmaceutical
Chemical Development
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 18G17, Pharma Machinery and Equipment

Products Featured at CPHI Milan 2024

  • Docetaxel API (Anhydrous)

    Product Docetaxel API (Anhydrous)

    Phyton commercially supplies docetaxel API (anhydrous). It is inspected by: USP/EP, US DMF 24675, CEP 2012-105, filed in Japan, Korea, China, India. Contact us for more information.
  • Paclitaxel API

    Product Paclitaxel API

    Phyton commercially supplies paclitaxel API (from Plant Cell Fermentation PCF™). It is inspected by: USP/EP, CEP 2011-324, US DMF 25525, filed in Japan, Korea, China, India. Contact us for more information.